UNDERWRITING AGREEMENTUnderwriting Agreement • November 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • New York
DiaMedica Therapeutics Inc. (the “Company”), a business corporation governed by the Canada Business Corporations Act (the “Corporations Act”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [●] (the “Firm Shares”) authorized but unissued voting common shares, without par value (the “Common Shares”), of the Company. The Company also proposes to grant to the several Underwriters an option to purchase up to an additional [●] Common Shares on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement (this “Agreement”) are herein collectively called the “Securities.”
Form of Representative’s WarrantRepresentative’s Warrant • November 27th, 2018 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations
THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “Securities ACT”), OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE SECURITIES ACT AND ALL APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION THEREFROM.
